vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $64.3M, roughly 1.3× CAMDEN NATIONAL CORP). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -38.1%, a 72.1% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 22.6%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
CAC vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $83.1M |
| Net Profit | $21.9M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 34.0% | -38.1% |
| Revenue YoY | — | 20.2% |
| Net Profit YoY | — | -27.9% |
| EPS (diluted) | $1.29 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | $83.1M | ||
| Q4 25 | $68.1M | $76.4M | ||
| Q3 25 | $65.4M | $83.3M | ||
| Q2 25 | $62.3M | $79.2M | ||
| Q1 25 | $60.1M | $69.2M | ||
| Q4 24 | $47.6M | $68.2M | ||
| Q3 24 | $45.0M | $58.4M | ||
| Q2 24 | $42.8M | $53.4M |
| Q1 26 | $21.9M | $-31.6M | ||
| Q4 25 | $22.6M | $-29.8M | ||
| Q3 25 | $21.2M | $-21.4M | ||
| Q2 25 | $14.1M | $-19.6M | ||
| Q1 25 | $7.3M | $-24.7M | ||
| Q4 24 | $14.7M | $-18.9M | ||
| Q3 24 | $13.1M | $-21.0M | ||
| Q2 24 | $12.0M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 41.5% | -40.6% | ||
| Q3 25 | 40.5% | -27.8% | ||
| Q2 25 | 28.5% | -28.0% | ||
| Q1 25 | 10.3% | -39.7% | ||
| Q4 24 | 38.7% | -28.9% | ||
| Q3 24 | 35.2% | -38.4% | ||
| Q2 24 | 34.7% | -50.3% |
| Q1 26 | 34.0% | -38.1% | ||
| Q4 25 | 33.1% | -39.1% | ||
| Q3 25 | 32.4% | -25.7% | ||
| Q2 25 | 22.6% | -24.7% | ||
| Q1 25 | 12.2% | -35.8% | ||
| Q4 24 | 30.8% | -27.6% | ||
| Q3 24 | 29.1% | -35.9% | ||
| Q2 24 | 28.0% | -48.0% |
| Q1 26 | $1.29 | $-0.56 | ||
| Q4 25 | $1.33 | $-0.54 | ||
| Q3 25 | $1.25 | $-0.38 | ||
| Q2 25 | $0.83 | $-0.35 | ||
| Q1 25 | $0.43 | $-0.45 | ||
| Q4 24 | $1.00 | $-0.34 | ||
| Q3 24 | $0.90 | $-0.40 | ||
| Q2 24 | $0.81 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | $514.4M | $51.7M |
| Stockholders' EquityBook value | $710.0M | $347.7M |
| Total Assets | $7.0B | $487.1M |
| Debt / EquityLower = less leverage | 0.72× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | $514.4M | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $710.0M | $347.7M | ||
| Q4 25 | $696.6M | $365.9M | ||
| Q3 25 | $676.4M | $380.3M | ||
| Q2 25 | $652.1M | $385.8M | ||
| Q1 25 | $640.1M | $389.2M | ||
| Q4 24 | $531.2M | $402.2M | ||
| Q3 24 | $529.9M | $241.2M | ||
| Q2 24 | $508.3M | $251.8M |
| Q1 26 | $7.0B | $487.1M | ||
| Q4 25 | $7.0B | $508.1M | ||
| Q3 25 | $7.0B | $511.5M | ||
| Q2 25 | $6.9B | $513.1M | ||
| Q1 25 | $7.0B | $519.4M | ||
| Q4 24 | $5.8B | $534.0M | ||
| Q3 24 | $5.7B | $374.1M | ||
| Q2 24 | $5.7B | $374.4M |
| Q1 26 | 0.72× | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
